Expanding Platform Development KORU Medical is actively developing a versatile platform infusion system in collaboration with SCHOTT Pharma, which aims to support both vial and prefilled syringe formats. This presents a significant opportunity to provide complementary products, accessories, and value-added solutions as they proceed with commercialization.

Focus on Large Volume Therapies The company's efforts to develop a customized Freedom System for large volume subcutaneous administration indicate a growing demand for innovative infusion solutions in this sector. There is potential to supply specialized infusion components, safety devices, or integrated systems tailored to large volume therapy markets.

Strategic Industry Engagements KORU Medical's active participation in major healthcare and investment conferences suggests strong engagement with industry leaders and investors. These events provide opportunities to introduce new products, discuss partnerships, and expand sales channels within the medical device and infusion therapy sectors.

Innovation Partnerships The company's partnership with Schott Pharma highlights its commitment to collaborating with innovative industry leaders. This opens doors to joint ventures, co-development projects, and co-marketing efforts that could lead to expanded market reach for infusion products and accessories.

Growth in Revenue and Market Reach With a revenue range of 25 to 50 million dollars and a focus on home infusion solutions, KORU Medical presents opportunities to target healthcare providers, home care agencies, and pharmaceutical companies seeking reliable infusion systems, especially as product development efforts translate into market expansion.